Testing effectiveness (Phase 2)Study completedNCT01262898
What this trial is testing
Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis
Who this might be right for
Gastroparesis
GlaxoSmithKline 79